The Patent Finder

Alnylam Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Alnylam Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 308 patents it holds.

Back to Alnylam Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,956,177Dsrna Compositions and Methods for Treating HPV Infection
now held by Novartis AG
In force
 · High confidence
In forceHigh confidence
US 8,642,076Lipid Containing Formulations
In force
 · Low confidence
In forceLow confidence
US 7,888,498Compositions and Methods for Inhibiting Expression of Ikk-B Gene
In force
 · High confidence
In forceHigh confidence
US 9,814,777Targeting Lipids
conveyed to Tekmira Pharmaceuticals Corporation - now held by Arbutus Biopharma Corporation
In force (reinstated)
 · High confidence
In force (reinstated)High confidence
US 8,148,344Compositions and Methods for Mediating Rnai in Vivo
now held by Eth Zurich
In force
 · High confidence
In forceHigh confidence
US 8,324,366Compositions and Methods for Delivering Rnai Using Lipoproteins
now held by Eth Zurich
In force
 · High confidence
In forceHigh confidence
US 8,722,082Lipids and Compositions for the Delivery of Therapeutics
In force
 · High confidence
In forceHigh confidence
US 9,707,292Novel Lipids and Compositions for the Delivery of Therapeutics
conveyed to Tekmira Pharmaceuticals Corporation - now held by Arbutus Biopharma Corporation
In force
 · High confidence
In forceHigh confidence
US 9,764,036Novel Lipids and Compositions for the Delivery of Therapeutics
conveyed to Tekmira Pharmaceuticals Corporation - now held by Arbutus Biopharma Corporation
In force
 · High confidence
In forceHigh confidence
US 10,117,941Novel Lipids and Compositions for the Delivery of Therapeutics
conveyed to Tekmira Pharmaceuticals Corporation - now held by Arbutus Biopharma Corporation
Grace period ended
 · Low confidence
Grace period endedLow confidence
10 of 724 records shown.
Pro members see all 724.
Pro members: see all 724 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited